These findings identify the JNK pathway as a critical mediator of CASK-related cerebellar pathology and support the potential utility of JNK inhibitors as therapeutic agents for neurodevelopmental disorders involving CASK dysfunction. The gene discussed is MAPK8; the disease is neurodevelopmental disorder.